Your browser is no longer supported. Please, upgrade your browser.
Settings
THMO ThermoGenesis Holdings, Inc. daily Stock Chart
THMO [NASD]
ThermoGenesis Holdings, Inc.
Index- P/E- EPS (ttm)-3.29 Insider Own15.07% Shs Outstand4.59M Perf Week-6.25%
Market Cap16.52M Forward P/E24.00 EPS next Y0.15 Insider Trans- Shs Float3.87M Perf Month16.13%
Income-9.50M PEG- EPS next Q0.00 Inst Own5.10% Short Float2.96% Perf Quarter-15.89%
Sales13.00M P/S1.27 EPS this Y84.40% Inst Trans- Short Ratio0.35 Perf Half Y-41.56%
Book/sh0.12 P/B30.00 EPS next Y400.00% ROA-58.50% Target Price7.50 Perf Year23.37%
Cash/sh0.70 P/C5.16 EPS next 5Y- ROE-247.10% 52W Range1.63 - 7.80 Perf YTD-18.18%
Dividend- P/FCF- EPS past 5Y46.10% ROI-105.20% 52W High-53.85% Beta1.07
Dividend %- Quick Ratio0.90 Sales past 5Y-4.00% Gross Margin43.60% 52W Low120.86% ATR0.73
Employees50 Current Ratio1.50 Sales Q/Q-37.00% Oper. Margin-42.30% RSI (14)51.12 Volatility11.16% 31.80%
OptionableNo Debt/Eq12.25 EPS Q/Q54.90% Profit Margin-72.80% Rel Volume0.52 Prev Close3.48
ShortableYes LT Debt/Eq12.25 EarningsMar 24 AMC Payout- Avg Volume330.68K Price3.60
Recom- SMA2019.20% SMA50-8.20% SMA200-9.50% Volume170,373 Change3.45%
May-23-18Initiated H.C. Wainwright Buy
Dec-22-15Downgrade Maxim Group Buy → Hold
Nov-17-15Reiterated Maxim Group Buy $7 → $1
Sep-21-15Upgrade H.C. Wainwright Neutral → Buy $2
May-15-15Downgrade H.C. Wainwright Buy → Neutral
Jun-26-14Initiated H.C. Wainwright Buy $5
Apr-24-14Initiated Maxim Group Buy $7
Apr-03-20 08:30AM  ThermoGenesis and ImmuneCyte's Rapid COVID-19 Testing Kit Featured on Local CBS News Titled: "Different Kind of Coronavirus Test" PR Newswire
Apr-02-20 10:33AM  ThermoGenesis' Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: "Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes" PR Newswire +14.29%
Mar-31-20 08:30AM  ThermoGenesis Announces that it has Notified the FDA of its Intent to Distribute the Company's Rapid COVID-19 Point-of-Care Test Kit PR Newswire +11.82%
Mar-27-20 02:52PM  ThermoGenesis Holdings Announces Closing Of $3.5 Million Registered Direct Offering Priced At-the-Market PR Newswire +8.57%
Mar-25-20 08:57AM  ThermoGenesis Holdings Announces $3.5 Million Registered Direct Offering Priced At-the-Market PR Newswire -46.00%
Mar-24-20 08:30AM  ThermoGenesis Holdings Announces 2019 Year End Financial Results And Provides Corporate Update PR Newswire +116.45%
Mar-18-20 08:30AM  Thermogenesis Holdings To Announce Financial Results For The Year Ended December 31, 2019 And Provide A Corporate Strategic Update PR Newswire -18.10%
Feb-19-20 04:00PM  ThermoGenesis Holdings Announces Partial Conversion Of Revolving Credit Agreement Held By Boyalife Asset Holding II PR Newswire
Jan-03-20 08:30AM  ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment PR Newswire
Jan-02-20 08:30AM  ThermoGenesis Holdings Announces Board of Directors and Management Changes PR Newswire
Dec-10-19 08:30AM  ThermoGenesis Holdings Updates 510(K) Listing With The FDA To Include Its Next Generation PXP®-1000 System For Advanced Cellular Processing PR Newswire +5.20%
Dec-05-19 08:30AM  ThermoGenesis Holdings To Present At The LD Micro 12th Annual Main Event PR Newswire
Nov-26-19 08:30AM  ThermoGenesis Holdings Closes Joint Venture Agreement With HealthBanks Biotech (USA) To Form ImmuneCyte Life Sciences PR Newswire
Nov-19-19 04:05PM  ThermoGenesis Holdings Announces Improved Third Quarter 2019 Financial Results And Provides Corporate Update PR Newswire -14.06%
Nov-14-19 03:44PM  ThermoGenesis Holdings To Postpone Third Quarter 2019 Earnings Release And Conference Call Until Tuesday November 19, 2019 PR Newswire
Nov-12-19 02:46PM  ThermoGenesis Holdings To Delay Third Quarter 2019 Earnings Release And Conference Call Until Thursday, November 14, 2019 PR Newswire +10.09%
Nov-06-19 08:30AM  ThermoGenesis Holdings To Announce Financial Results For The Third Quarter Ended September 30, 2019 And Provide A Corporate Strategic Update PR Newswire
Oct-31-19 06:30AM  Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus PR Newswire +7.31%
Oct-24-19 08:30AM  Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire -6.91%
Oct-23-19 09:27AM  Here's What We Think About Cesca Therapeutics Inc.'s (NASDAQ:KOOL) CEO Pay Simply Wall St. -5.79%
12:47AM  Cesca to launch immune cell banking service American City Business Journals
Oct-22-19 06:30AM  Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services PR Newswire
Oct-14-19 08:30AM  Cesca Therapeutics To Present At The 2019 Bio Investor Forum PR Newswire -5.69%
Oct-09-19 09:14AM  Top Ranked Momentum Stocks to Buy for October 9th Zacks
Oct-02-19 08:30AM  Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee PR Newswire
Sep-30-19 10:05AM  Small Caps Win in September: 5 Best ETFs & Stocks Zacks
Sep-25-19 10:25AM  ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices PR Newswire
Sep-18-19 10:20AM  Accelerate Diagnostics (AXDX) Jumps: Stock Rises 9.4% Zacks
Sep-09-19 12:17PM  A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019 Benzinga +16.81%
08:30AM  Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products PR Newswire
Sep-03-19 08:30AM  Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference PR Newswire
Aug-27-19 09:04AM  4 Domestic Stocks to Buy on Global Economic Uncertainties Zacks
Aug-26-19 05:47PM  Arcadia names new CEO, forecasts big revenue gains; stock soars American City Business Journals
Aug-13-19 04:05PM  Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire +10.29%
Aug-06-19 08:30AM  Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR Newswire
Jul-23-19 08:30AM  America's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II System PR Newswire
Jul-05-19 10:25AM  Some Cesca Therapeutics (NASDAQ:KOOL) Shareholders Have Copped A 99% Share Price Wipe Out Simply Wall St. +13.56%
Jun-26-19 08:30AM  Cesca Therapeutics Regains Nasdaq Listing Compliance PR Newswire
Jun-25-19 08:30AM  Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India PR Newswire
Jun-18-19 10:27AM  ThermoGenesis Cord Blood Processing System Wins Health Canada Approval Benzinga +11.11%
08:30AM  ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing PR Newswire
Jun-05-19 08:30AM  ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium PR Newswire +11.83%
Jun-04-19 12:00PM  Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock PR Newswire
May-16-19 09:02AM  Does Market Volatility Impact Cesca Therapeutics Inc.'s (NASDAQ:KOOL) Share Price? Simply Wall St.
May-14-19 04:05PM  Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update PR Newswire
May-07-19 08:30AM  Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14 PR Newswire +5.22%
May-06-19 10:30AM  Will Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-17-19 08:00AM  ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research Market PR Newswire
Apr-10-19 08:00AM  ThermoGenesis AXP® II and PXP® Systems Now Registered and Available in Thailand PR Newswire
Mar-25-19 04:05PM  Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update PR Newswire
Mar-20-19 08:00AM  Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25 PR Newswire
Feb-25-19 08:00AM  ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells PR Newswire
Feb-11-19 08:30AM  ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark PR Newswire
Feb-06-19 08:30AM  Cesca Therapeutics to Present at the BIO CEO & Investor Conference PR Newswire
Feb-01-19 08:30AM  ThermoGenesis Corp Signs Strategic Supply Agreement with Orthohealing Center Management to Provide it's PXP® Point-of-Care System to Orthohealing Method Physician Members PR Newswire
Jan-21-19 08:30AM  ThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series Cell Processing Disposables PR Newswire
Jan-04-19 08:30AM  Cesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing Platform PR Newswire +13.97%
Nov-20-18 09:05AM  4 Healthcare Stocks You Should Get To Know Before 2019 ACCESSWIRE -18.48%
Nov-19-18 09:56AM  Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking PR Newswire +51.32%
Nov-14-18 04:05PM  Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update PR Newswire +5.08%
Nov-13-18 08:30AM  Cesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing Devices PR Newswire +8.46%
Nov-07-18 08:30AM  Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14 PR Newswire
Nov-06-18 10:30AM  Will Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should Know Zacks
Nov-02-18 06:45PM  Cesca Therapeutics (KOOL) Dips More Than Broader Markets: What You Should Know Zacks
Oct-18-18 05:45PM  Cesca Therapeutics (KOOL) Stock Moves -0.73%: What You Should Know Zacks
Oct-16-18 05:27PM  Cesca Therapeutics lays off three executives to cut costs American City Business Journals +6.05%
08:30AM  Cesca Therapeutics Announces Cost Reduction Measures Aimed at Achieving Cash Flow Positive Position in 2019 PR Newswire
Sep-13-18 08:30AM  Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018 PR Newswire +9.88%
Sep-05-18 08:30AM  Cesca Therapeutics Provides Commercialization Update For Its X-Series Product Line PR Newswire -9.04%
Aug-30-18 08:30AM  Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference GlobeNewswire +8.09%
Aug-29-18 08:30AM  Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit GlobeNewswire +21.32%
Aug-15-18 08:48AM  The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue Benzinga
Aug-14-18 08:23AM  The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut Benzinga -16.18%
Aug-13-18 04:05PM  Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 08:30AM  Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13 GlobeNewswire
Jul-16-18 08:30AM  Cesca Therapeutics Announces the Launch of its PXP System for Automated Processing of Bone Marrow Cells GlobeNewswire
Jun-22-18 07:18AM  Free Research Reports on Boston Scientific and Three More Medical Equipment Stocks ACCESSWIRE -6.58%
Jun-06-18 08:30AM  Cesca Therapeutics Announces Exhibition at The Orthobiologic Institutes 9th Annual PRP & Regenerative Medicine Symposium GlobeNewswire
Jun-04-18 05:56PM  Rancho Cordova-based Cesca Therapeutics cutting about 20 jobs American City Business Journals
08:30AM  Cesca Therapeutics Announces Reduction in Operating Expenses GlobeNewswire
May-31-18 02:02PM  Cesca Therapeutics Incs (NASDAQ:KOOL) Profit Outlook Simply Wall St.
May-23-18 02:47PM  Cesca Therapeutics Snags Bullish HC Wainwright Initiation On CAR-T Opportunity Benzinga
08:30AM  Cesca Therapeutics Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy GlobeNewswire
May-18-18 11:12AM  Cesca Announces Closing of $5.5 Million Public Offering GlobeNewswire
May-17-18 08:10AM  Todays Research Reports on Stocks to Watch: Abaxis, Inc. and Cesca Therapeutics ACCESSWIRE
May-16-18 12:00PM  Cesca Prices $5.5 Million Public Offering GlobeNewswire -30.92%
08:10AM  Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings Benzinga
May-14-18 04:05PM  Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
12:15PM  Cesca Therapeutics Inc. to Host Earnings Call ACCESSWIRE
May-09-18 08:30AM  Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14 GlobeNewswire
May-04-18 05:00PM  Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series Cellular Processing Systems GlobeNewswire
Apr-25-18 08:30AM  Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences GlobeNewswire -7.14%
Apr-24-18 08:30AM  Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Products That Provide Automated, Closed System Cellular Processing GlobeNewswire
Apr-18-18 07:30AM  Blog Exposure - AcelRx Pharma Completes the Human Factors Study for DSUVIA ACCESSWIRE +14.10%
Apr-17-18 02:21PM  Has Cesca Therapeutics Inc (NASDAQ:KOOL) Improved Earnings Growth In Recent Times? Simply Wall St.
08:30AM  Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing GlobeNewswire
Apr-03-18 08:30AM  Cesca Therapeutics Inc. Announces Release of X-Mini Cell Selection Kit for the CAR-T Research Market GlobeNewswire
Mar-28-18 07:00AM  Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting GlobeNewswire
Mar-26-18 05:53PM  Cesca raising $1.4 million in direct offering of stock American City Business Journals
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company operates through two segments, Device and Clinical Development. It manufactures and markets products for clinical bio-banking applications, including AXP Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company also offers PXP Point-of-Care System, an automated sterile system that allows for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification using the company's proprietary buoyance-activated cell sorting (BACS) technology. In addition, it provides manual processing sets comprising transfer/freezing bag sets, freezing bags, and cell wash/infusion bag sets. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xu XiaochunCEODec 26Buy3.33683,8242,277,134683,824Jan 03 07:16 PM